VALEANT PHARMACEUTICALS INTERNATIONAL, I – Trademark Portfolio

Entity Type: 03

VALEANT PHARMACEUTICALS INTERNATIONAL, I holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 6 filings in this category. Currently, 6 trademarks are registered. Notable registered marks include TARGRETIN, TERMINATOR 10, OCEAN COMPLETE, and OCEAN FOR KIDS. The owner is based in DUBLIN.

3013 LAKE DRIVE

CITYWEST BUSINESS CAMPUS

DUBLIN 24 , IE

6 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

VALEANT PHARMACEUTICALS INTERNATIONAL, I's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (6 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does VALEANT PHARMACEUTICALS INTERNATIONAL, I have?

VALEANT PHARMACEUTICALS INTERNATIONAL, I has 6 U.S. trademarks filed with the USPTO. Of these, 6 registered.

What trademark classes does VALEANT PHARMACEUTICALS INTERNATIONAL, I file in?

VALEANT PHARMACEUTICALS INTERNATIONAL, I files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are VALEANT PHARMACEUTICALS INTERNATIONAL, I's most well-known trademarks?

VALEANT PHARMACEUTICALS INTERNATIONAL, I's registered trademark portfolio includes well-known marks such as TARGRETIN, TERMINATOR 10, OCEAN COMPLETE, and OCEAN FOR KIDS. These are among 6 currently registered trademarks in the portfolio.

What is VALEANT PHARMACEUTICALS INTERNATIONAL, I's trademark registration success rate?

VALEANT PHARMACEUTICALS INTERNATIONAL, I has a 100% trademark registration rate, with 6 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.